D Collett

Summary

Affiliation: NHS Blood and Transplant
Country: UK

Publications

  1. doi request reprint The UK scheme for mandatory continuous monitoring of early transplant outcome in all kidney transplant centers
    Dave Collett
    Statistics and Clinical Audit, NHS Blood and Transplant, Bristol, United Kingdom
    Transplantation 88:970-5. 2009
  2. doi request reprint Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit
    D Collett
    Statistics and Clinical Audit, NHS Blood and Transplant, Bristol BS34 8RR, UK
    Am J Transplant 10:1889-96. 2010
  3. pmc Life expectancy of adult liver allograft recipients in the UK
    K Barber
    UK Transplant, Bristol, UK
    Gut 56:279-82. 2007

Collaborators

Detail Information

Publications3

  1. doi request reprint The UK scheme for mandatory continuous monitoring of early transplant outcome in all kidney transplant centers
    Dave Collett
    Statistics and Clinical Audit, NHS Blood and Transplant, Bristol, United Kingdom
    Transplantation 88:970-5. 2009
    ..The value and limitations of the scheme are discussed along with changes that may improve its utility as a tool for self-assessment and central oversight...
  2. doi request reprint Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit
    D Collett
    Statistics and Clinical Audit, NHS Blood and Transplant, Bristol BS34 8RR, UK
    Am J Transplant 10:1889-96. 2010
    ..Patterns in standardized incidence ratios over time since transplantation are different for different types of transplant recipient, as well as for different malignancies. These results have implications for a national screening program...
  3. pmc Life expectancy of adult liver allograft recipients in the UK
    K Barber
    UK Transplant, Bristol, UK
    Gut 56:279-82. 2007
    ..Although there are numerous data on patient and graft survival after liver transplantation, life expectancy and possible loss of life (compared with a normal matched population) in those who survive remains unknown...